Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2014; 20(45): 17235-17243
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17235
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17235
Table 1 Quality assessment of the included randomized controlled trials based on the Jadad scoring system
Table 2 Quality assessment of the included non-randomized controlled trials based on the Newcastle-Ottawa scale
Table 3 Characteristics of the included trials
Ref. | Design | Country | Patients, n (AAH/CAH) | Disease | Tumor size, cm (AAH/CAH) | Tumor≥5 cm |
Lai et al[1] | CCT | China (Hong Kong) | 25/34 | HCC | 12.8/8.4 | 85% |
Liu et al[3] | CCT | China (Hong Kong) | 54/106 | HCC | 10.3/10.5 | 100% |
Liu et al[7] | RCT | China (Hong Kong) | 60/60 | HCC | 10.5/10.0 | 100% |
Takács et al[14] | CCT | Hungary | 52/67 | HCC or MHC | 11.6/10.0 | NR |
Wang et al[15] | CCT | China (Taiwan) | 14/11 | HCC | 12.5/12.0 | 100% |
Wu et al[13] | CCT | China (Taiwan) | 33/38 | HCC | 12.0/9.7 | 100% |
Li et al[12] | CCT | China | 92/96 | HCC | 12.2/10.4 | 100% |
Capussotti et al[16] | RCT | Italy | 33/32 | HCC or MHC | 6.0/5.2 | NR |
Table 4 Characteristics of patients in included studies
Ref. | AAH/CAH | ||||||
Mean blood loss(L) | Transfusion requirements(n:total) | Hospital stay(d) | Mortality,n (%) | Recurrence,n (%) | Complication,n (%) | Tumor rupture(n:total) | |
Lai et al[1] | 3.2 (2.0-4.4)/3.1 (2.0-4.2)1 | NR | NR | 1 (4)/2 (5.9) | NR | 21 (84)/13 (38.2) | 3:25/1:34 |
Liu et al[3] | 2.0 (0.6-2.0)/2.5 (0.2-2.0)1 | 31:54/86:106 | NR | 0 (0)/14 (13.2) | NR | 25 (46.3)/56 (52.8) | 1:54/7:106 |
Liu et al[7] | 0.8 (0.5-1.4)/1.0 (0.5-2.2)2 | 4:60/17:60 | 11 (7.3-15)/12.5 (8-19)2 | 1 (1.7)/6 (0.28) | 33 (55.9)/30 (55.6) | 16 (26.7)/20 (33.3) | 1:60/1:60 |
Takács et al[14] | NR | 30:52/49:67 | 20.4 ± 13.5/18.3 ± 6.9 | 0 (0)/2 (3.0) | NR | 20 (38.5)/24 (35.8) | NR |
Wang et al[15] | 0.4 (0.2-0.9)/1.0 (0.5-1.2)2 | 3:14/8:11 | 15 (10.7-19.7)/16 (13-19)2 | 0 (0)/0 (0) | NR | 9 (64.3)/8 (72.7) | NR |
Wu et al[13] | 0.5 (0.3-0.7)/0.6 (0.3-1.0)1 | 4:33/18:38 | 10 (8.0-19.5)/11 (8.0-14.0)1 | 2 (6.1)/5 (13.2) | 12 (38.7)/27 (81.8) | 8 (24.2)/16 (42.1) | 4:33/4:38 |
Li et al[12] | 1.2 ± 1.1/2.1 ± 2.03 | 38:92/54:96 | 23 ± 11/24 ± 103 | 2 (2.2) /3 (3.1) | 40 (47.6)/50 (60.2) | 13 (14.1)/17 (17.7) | NR |
Capussotti et al[16] | 0.4 ± 0.66/0.5 ± 0.533 | 6:33/3:32 | 10.0 ± 6.59/11.5 ± 13.63 | 1 (3.0)/1 (3.1) | NR | 17 (51.5)/18 (56.3) | 0:33/0:32 |
Total | - | 116:338/ 235:410 | - | 7 (1.9)/33 (7.4) | 85 (48.9)/107 (63.0) | 129 (35.5)/172 (38.7) | 9:205/ 13:270 |
-
Citation: Li L, Wang HQ, Wang Q, Yang J, Yang JY. Anterior
vs conventional approach hepatectomy for large liver cancer: A meta-analysis. World J Gastroenterol 2014; 20(45): 17235-17243 - URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17235.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17235